Fei Peng

Harvard University

H-index: 30

North America-United States

About Fei Peng

Fei Peng, With an exceptional h-index of 30 and a recent h-index of 26 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Nanosafety, Nanotoxicology, Bioimaging, Disease diagnosis and therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Advanced extracellular vesicle bioinformatic nanomaterials: from enrichment, decoding to clinical diagnostics

Advances in extracellular vesicle nanotechnology for precision theranostics

Coupling programmed cell death 1-positive tumor-infiltrating t cells with anti-programmed cell death 1 antibody improves the efficacy of adoptive T-cell therapy

Mesenchymal stem cell‐derived extracellular vesicles with high PD‐L1 expression for autoimmune diseases treatment

Assessment of Glial Fibrillary Acidic Protein Binding to the Surface of Leukocytes with Dark‐Field Imaging and Computational Analysis

Recent progress in plasmonic nanoparticle‐based biomarker detection and cytometry for the study of central nervous system disorders

Fei Peng Information

University	Harvard University
Position	Harvard Medical School/Massachusetts General Hospital
Citations(all)	4265
Citations(since 2020)	2458
Cited By	2967
hIndex(all)	30
hIndex(since 2020)	26
i10Index(all)	40
i10Index(since 2020)	40
Email	Access Email
University Profile Page	Harvard University
Google Scholar	View Google Scholar Profile

Fei Peng Skills & Research Interests

Nanosafety

Nanotoxicology

Bioimaging

Disease diagnosis and therapy

Top articles of Fei Peng

Title	Journal	Author(s)	Publication Date
Advanced extracellular vesicle bioinformatic nanomaterials: from enrichment, decoding to clinical diagnostics		Yawei Zhang Liang Zhao Yaocheng Li Shuangshuang Wan Zhiyao Yuan ...	2023/10/6
Advances in extracellular vesicle nanotechnology for precision theranostics		Qian Wu Siyuan Fu Hanyang Xiao Jiaxin Du Fang Cheng ...	2023/1
Coupling programmed cell death 1-positive tumor-infiltrating t cells with anti-programmed cell death 1 antibody improves the efficacy of adoptive T-cell therapy	Cytotherapy	Jiacheng Chu Chenya Wang Qingle Ma Huaxing Dai Jialu Xu ...	2022/3/1
Mesenchymal stem cell‐derived extracellular vesicles with high PD‐L1 expression for autoimmune diseases treatment	Aging cell	Akaitz Dorronsoro Fernando E Santiago Diego Grassi Tianpeng Zhang Ruenn Chai Lai ...	2021/4
Assessment of Glial Fibrillary Acidic Protein Binding to the Surface of Leukocytes with Dark‐Field Imaging and Computational Analysis		Fei Peng Sinyoung Jeong German Gonzalez Haley Marks Alexander Ho ...	2021/3
Recent progress in plasmonic nanoparticle‐based biomarker detection and cytometry for the study of central nervous system disorders		Fei Peng Sinyoung Jeong Alexander Ho Conor L Evans	2021/11